Future Immunotherapies in Multiple Sclerosis Future Immunotherapies in Multiple Sclerosis2018-01-17T17:01:53-05:00
Adenosine: an endogenous regulator of innate immunity Adenosine: an endogenous regulator of innate immunity2018-01-17T17:01:53-05:00
Immunomodulatory and neuroprotective effects of inosine Immunomodulatory and neuroprotective effects of inosine2018-01-17T17:01:53-05:00
Immunohistopathology to guide multiple sclerosis treatment Immunohistopathology to guide multiple sclerosis treatment2018-01-17T17:01:53-05:00
Balancing susceptibility to infection and autoimmunity: a role for leptin? Balancing susceptibility to infection and autoimmunity: a role for leptin?2018-01-17T17:01:53-05:00
Ibuprofen-like activity in extra-virgin olive oil Ibuprofen-like activity in extra-virgin olive oil2018-01-17T17:01:47-05:00
Environmental risk factors in multiple sclerosis Environmental risk factors in multiple sclerosis2018-01-17T17:01:47-05:00
Immunotherapies: cause for measured optimism Immunotherapies: cause for measured optimism2018-01-17T17:01:47-05:00
